Peter Brodersen is a Professor at the Department of Biology, University of Copenhagen , specializing in Bioinformatics and RNA Biology . His research focuses on RNA modification (m6A), YTHDF proteins, and small RNA pathways in plants. Recent research trends from his group include: (1) molecular mechanisms of ARGONAUTE-small RNA interactions, (2) m6A-YTHDF regulatory systems in plant development, and (3) RNAi-independent roles of DICER-LIKE proteins in antiviral defense. Collaborations span Denmark and international institutions. Publications highlight cross-disciplinary work bridging computational biology and experimental plant genetics. Key subfields include RNA structure, epigenetic regulation, and antiviral immunity.
Hans H. Wandall is Professor and Deputy Head of Department at the University of Copenhagen's Department of Cellular and Molecular Medicine, Faculty of Health Sciences. He serves as Group Leader and Vice-Director of the Copenhagen Center for Glycomics. His educational background includes a PhD in Glycobiology (2004), medical licensure (2001), and MD from University of Copenhagen (1999). Research focuses on glycobiology using gene editing and tissue models to understand glycan functions in: Tissue development and cancer biology Host-virus interactions (HSV-1, Ebola) Stem cell regulation and regenerative medicine Glycan-based therapeutic development Recent publications demonstrate interdisciplinary approaches combining glycoproteomics, virology, and cancer biology, with emphasis on O-glycosylation mechanisms and viral pathogenesis. Awards & Recognition: ERC Consolidator Grant (2017) Lundbeck Foundation Ascending Investigator (2019) Sapere Aude Research Leader Award (2012) Young Scientist Award (2003) Leads multiple funded projects from Lundbeck Foundation, Novo Nordisk Foundation, and Danish National Research Foundation. Supervises doctoral candidates and postdoctoral researchers while directing the GlycoMedicine research group. Founded biotech ventures including GO-Therapeutics and Hemab ApS.
Professor Peter Højrup is affiliated with the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, focusing on protein structure and function through advanced biochemical techniques such as mass spectrometry and chemical cross-linking. His research spans biomedical mass spectrometry, systems biology, and proteomics, with a particular emphasis on endoplasmic reticulum proteins like calreticulin and calnexin. Education: PhD in Molecular Biology (1986, Odense University), MSc in Molecular Biology (major) and Chemistry (minor) (1982, University of Aarhus) His research interests include: Developing methods for determining protein 3D structures and interactions via chemical cross-linking and mass spectrometry. Fast glycosylation analysis of immunoglobulins and cancer markers. De novo proteomics of fish mucus proteins. The articles highlight trends in mass spectrometry applications, structural biology, and glycosylation studies, with recent work on SARS-CoV-2 epitope mapping, therapeutic antibody characterization, and host cell protein quantitation. Supervision includes training postdocs, PhD, MSc, and BSc students, though specific student names are not provided.
Svend Birkelund is a Professor and Head of Research Group in the Department of Health Science and Technology at Aalborg University, Faculty of Medicine. His academic work is centered on medical microbiology and immunology, with a strong emphasis on molecular bacterial pathogenesis. Doctor of Medical Science (DMSc), Aarhus University, 1992 PhD, University of Aarhus, 1989 MD, University of Copenhagen, 1983 His research focuses on how pathogenic bacteria such as Chlamydia trachomatis and Klebsiella pneumoniae interact with the human immune system, particularly the complement system and innate immune responses. His recent work explores serum resistance mechanisms, leukocyte migration via aquaporins, and biomarker discovery in inflammatory joint diseases. He contributes to UN Sustainable Development Goals related to health and well-being. Analysis of his recent publications reveals a strong trend in immunology and microbiology, with increasing use of proteomics and systems biology approaches. His work spans fundamental host-pathogen interactions, clinical immunology, and translational applications in diagnostics and therapy. He has contributed to significant research projects, including: Elimination of microorganisms by the innate immune system (Obel Family Foundation) Biomarkers in Osteoarthritis Interleukin-1 in inflammatory diseases Analysis of citrullinated peptides in autoimmune triggers His datasets on proteomic analysis of synovial fluid and complement deposition on Chlamydia are publicly available. He has supervised multiple PhD students and is frequently engaged in public discourse on antibiotic-resistant bacteria through media appearances. He is actively involved in interdisciplinary collaborations and leads a research group focused on advancing understanding of infectious and inflammatory diseases through molecular and immunological approaches.
Edwin Hwu is an Associate Professor at the Department of Health Technology, Technical University of Denmark (DTU), leading the MIDAS research group focused on Micro Medical Devices and hardware hacking-based technologies. His work spans Atomic Force Microscopy (AFM), 3D printing, and drug delivery systems. Research Focus: Skin barrier function assessment, liver fibrosis treatment using siRNA, and repurposing consumer electronics for biomedical sensing. Projects: Currently leads "Repurposing Microelectronics for Gut Sensing" (2025-2028) and previously completed "Rapid Clinical Assessment of Skin Barrier Function by Corneocytes Nanotexture" (2021-2023). His publications highlight interdisciplinary work in Atomic Force Microscopy , 3D Printing , and Nanoscale Engineering , with applications in dermatology and neglected tropical diseases. He actively engages in guest lectures on hacking consumer electronics for scientific research. Awards: VILLUM Experiment Grant for micro/nanoscale 3D printing projects. Hwu supervises PhD students and collaborates with researchers like Anja Boisen (DTU) and others, focusing on translating microelectronics into medical solutions. His lab develops compact, high-resolution devices for diagnostics and drug delivery.
Hau Van Nguyen is a Researcher in the Drug Delivery and Sensing group under the Department of Health Technology at the Technical University of Denmark . His work focuses on developing microfluidic platforms for biomedical applications, particularly studying virus infections and periodontitis. Research Areas : Microfluidics, virology, periodontitis, in vitro models, and lab-on-a-chip technology. Publications : Recent studies include centrifugal microfluidic platforms for HSV-1 infection research and dynamic in vitro models for periodontitis. Activities : Active in conference presentations discussing microfluidic cell culture systems and their applications in infectious disease research.
Jakob Møller-Jensen is an Associate Professor and Head of Department at the Department of Biochemistry and Molecular Biology, University of Southern Denmark. With a PhD in his field, he maintains an active research program with 67 publications to date and leads departmental operations. His research focuses on molecular microbiology with emphasis on host-pathogen interactions and pathogenic bacteria. His work primarily investigates Escherichia coli and uropathogenic strains, examining their behavior in urinary tract infections, plasmid dynamics, and bacterial morphology changes during infection processes. His research fingerprint shows strong expertise in Escherichia coli (100%), Uropathogenic Escherichia Coli (95%), Urinary Tract infections (43%), Plasmid biology (43%), RNA mechanisms (31%), Fimbria (31%), Gene Expression (29%), and Caenorhabditis Elegans models (27%). Analysis of his recent publications reveals a consistent focus on bacterial pathogenesis mechanisms, particularly how E. coli adapts to host environments, with special attention to urinary tract infections, bacterial morphology changes, and antibiotic resistance mechanisms. His work bridges fundamental molecular microbiology with clinical implications for infection treatment. Dr. Møller-Jensen has been involved in teaching Chemistry, Biology and Molecular Biology courses from 2009-2019, and has participated in numerous academic activities including conferences, workshops, and seminars. His collaborative network spans multiple countries and research institutions. His current research projects include significant funding from Lundbeckfonden on cellular senescence in cancer (2024-2029), NANOCHEM for ultrahigh resolution chemical characterization (2022-2028), metabolic regulation of mammalian DNA replication (2021-2026), and gut bacteria as biomarkers for colorectal cancer (2023-2025).
Viktoria Weber is a full Professor of Applied Biochemistry and Vice-Rector for Research at Danube University Krems, where she also leads the Department for Biomedical Research and the Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis. She previously conducted research at the Medical University of Vienna and holds a PhD and habilitation in glycobiology from the University of Natural Resources and Life Sciences, Vienna. PhD in Glycobiology, University of Natural Resources and Life Sciences, Vienna Habilitation, University of Natural Resources and Life Sciences, Vienna Degree in Biotechnology, University of Natural Resources and Life Sciences, Vienna Her research focuses on cellular activation at the blood-biomaterial interface, extracellular vesicles in thrombogenesis and immunomodulation, and advanced diagnostics for sepsis and bloodstream infections. She integrates biochemical, immunological, and clinical approaches to understand host responses in extracorporeal circuits and infectious disease. The recent publication trends highlight consistent contributions in extracellular vesicles , sepsis , immunothrombosis , and biomaterial compatibility . These works span molecular mechanisms to translational diagnostics, reflecting a strong emphasis on bridging basic science with clinical applications in critical care and biomedical engineering. She holds leadership roles in major scientific organizations: Co-founder and Vice President, Austrian Society for Extracellular Vesicles Vice President, Austrian Association for Molecular Life Sciences and Biotechnology Board Member, European Society for Artificial Organs She advises national and international funding agencies as an expert reviewer and leads multidisciplinary research teams focused on sepsis therapy and blood-biomaterial interactions. Her department hosts collaborative projects in biomedical detection systems and innovative treatment strategies. She also oversees research strategy as Vice-Rector, supporting institutional scientific development. Her research is conducted within the Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis and the Department for Biomedical Research, which foster interdisciplinary collaboration between biochemists, clinicians, and engineers to develop novel diagnostic and therapeutic solutions.
Søren Feddersen serves as an Associate Professor in the Department of Clinical Research at the University of Southern Denmark's Faculty of Health Sciences, with dual appointments at Odense University Hospital (OUH) and the Research Unit of Clinical Biochemistry in Odense. His work bridges laboratory science and clinical applications through biomarker discovery across multiple disease domains. His research centers on molecular mechanisms in cardiovascular pathology, cancer progression, and infectious disease diagnostics , with particular expertise in microRNA profiling , genetic variant analysis , and cytokine signature identification . Current projects investigate JAK2 mutations in aortic aneurysms, pharmacogenomics in breast cancer treatment, and novel biomarkers for prostate cancer and tuberculosis diagnosis. Recent publications (2024-2025) demonstrate a strong translational focus through population-based cohort studies and diagnostic validation trials , frequently involving multi-center collaborations across cardiology, oncology, and immunology. His work consistently emphasizes clinically applicable biomarker discovery using plasma, blood, and tissue samples. Dr. Feddersen has supervised at least one Ph.D. thesis as indicated by institutional records. His collaborative network spans Karolinska Institutet (KI), Odense University Hospital, and international research teams, reflecting engagement in large-scale funded projects though specific grant details aren't publicly itemized. He operates within the Research Unit of Clinical Biochemistry at OUH, contributing to SDU's clinical research infrastructure through interdisciplinary teams focused on molecular diagnostics and precision medicine applications.
Søren Rosendahl is a Professor in Ecology and Evolution at the Department of Biology, Faculty of Science, University of Copenhagen. He holds a PhD and has been recognized as a Knight (Ridder af Dannebrog) for his contributions to science. His academic career spans over three decades at the University of Copenhagen, where he served as Assistant Professor (1991), Associate Professor (1994), and Professor (2000) in the Department of Mycology, which later became part of the Department of Biology. From 2010-2019, he served as Deputy Head of the Department of Biology. Education: 1984: Master of Science (Cand.scient.) in biology, University of Copenhagen 1985: Practical and theoretical training as high school teacher in biology 1989: Ph.D. (Lic.scient) at Institut for Sporeplanter Professor Rosendahl specializes in molecular ecology, population genetics, and evolution of fungi, with particular emphasis on biotrophic symbionts and parasites. His research encompasses Fusarium, Penicillium, Oomycota (Peronosporamycota), arbuscular mycorrhizal fungi (AMF) in Glomales, and fungi associated with insects. He employs advanced genomic techniques including rad-sequencing, microsatellites, SNPs, and DNA sequencing to study fungal diversity and distribution patterns. His BioMark project applies population genomics to predict emerging epidemics of Phytophthora infestans (Potato late blight). He also investigates molecular diversity of AMF fungi in agricultural and natural environments using evolutionary and demographic models based on coalescence and MCMC Bayesian statistics. Analysis of Professor Rosendahl's recent publications reveals a strong interdisciplinary focus spanning fungal ecology, medical microbiology, and agricultural science. His work demonstrates consistent application of molecular genetic approaches to understanding fungal community dynamics across diverse ecosystems - from soil microbial communities to human gut microbiomes. The trend shows increasing integration of computational approaches including hierarchical joint species modeling and co-occurrence networks for microbial community data analysis. His research bridges fundamental fungal biology with practical applications in agriculture, medicine, and environmental science. Scientific Recognition: Knight (Ridder af Dannebrog) Throughout his career, Professor Rosendahl has held numerous leadership and advisory positions. He served as Head of the Department of Mycology (1998-2001), Coordinator for the Bachelor degree in Industrial Science (2002-2005), and Head of the Study Board for Biology (2005-2007). He has represented Danish higher education on the Biology/Biotechnology board in the Ministry of Education since 2010 and has consulted for international organizations including the EC Commission, Norwegian Ministry for Education, and European Baccalaureate Unit. His external collaborations include significant work with Novozymes Biologicals and Thomsen BioScience A/S. Professor Rosendahl maintains active research collaborations through his membership in the European culture collection (BEG - Bank of European Glomales) and has served as Danish representative in multiple COST actions. His research group appears to focus on fungal population genetics with applications spanning agricultural systems, natural ecosystems, and medical contexts.
Rafael Pinilla-Redondo is an Assistant Professor in the Department of Biology at the University of Copenhagen's Faculty of Science, where he leads the Bacterial Immunity research group within the Section of Microbiology. His laboratory, located at Universitetsparken 15 in Copenhagen, focuses on the molecular mechanisms of bacterial defense systems against phages. His research interests center on bacterial immunity, particularly how CRISPR-Cas and other bacterial immune systems evolve and function. He investigates the molecular mechanisms driving these complex systems to answer fundamental biological questions and develop novel biotechnologies. His work spans phage biology, molecular evolution, molecular biology, and genetics, with a specific emphasis on bacterial defense mechanisms against viral threats. Dr. Pinilla-Redondo's recent publications demonstrate significant contributions to understanding bacterial immune systems, particularly CRISPR-Cas variants, retrons, and other defense mechanisms. His research shows strong trends in structural biology approaches to understanding immune system function, with increasing focus on the supramolecular organization of defense complexes and their evolutionary implications. Villum Young Investigator grant (2023) His laboratory maintains active collaborations across multiple institutions, as evidenced by the international authorship on his publications. The lab has developed specialized software tools including CRISPR-Cas Typer for automated identification of CRISPR-Cas loci, Plasmid Network for exploring the global plasmidome, and Hoodini (coming soon) for genome neighborhood visualization. His work has received significant attention, with multiple papers picked up by news outlets, blogged about, and widely shared on social media platforms. The Pinilla-Redondo Lab is part of the vibrant microbiology research community at the University of Copenhagen, focusing on the evolutionary arms race between bacteria and their viral predators.
Lisbeth Samsø Schmidt serves as a Clinical Associate Professor in the Department of Clinical Medicine, Paediatrics at the University of Copenhagen. Her clinical work appears to be affiliated with the Capital Region of Denmark (Region Hovedstaden), as indicated by her regionh.dk email address. She maintains an active research profile with numerous publications in high-impact journals including The Lancet and Acta Pædiatrica. Dr. Schmidt's research interests focus on pediatric infectious diseases, with particular emphasis on neurological infections, antibiotic treatments, and post-viral inflammatory conditions. Her work often involves large-scale, nationwide cohort studies in Denmark, examining epidemiological patterns and treatment efficacy across various pediatric conditions. She frequently collaborates with researchers at Copenhagen University Hospital and other Danish medical institutions. Her recent publications demonstrate a strong focus on optimizing antibiotic treatments for children with infections, investigating diagnostic approaches for neurological conditions in pediatric patients, and studying the impact of the COVID-19 pandemic on childhood infectious disease patterns. Her research has been cited extensively and has received attention from news outlets and social media platforms. Dr. Schmidt has contributed to significant clinical research including multicenter trials on antibiotic administration routes, studies on neuroborreliosis treatment in children, and investigations into multisystem inflammatory syndrome. Her collaborative network spans multiple Danish medical institutions with a focus on evidence-based pediatric care.
Lars Rønn Olsen serves as a Professor in the Department of Immunology and Microbiology within the Faculty of Health and Medical Sciences at the University of Copenhagen. He maintains dual affiliation with the Skin Immunology Research Center, where his work bridges experimental immunology and computational approaches to address complex immune challenges. His research concentrates on Immunology , Microbiology , and Computational Immunology , with specialized focus on vaccine response prediction. Recent work examines computational models for Bordetella pertussis vaccination immunity, integrating multi-omics data to forecast immune outcomes. This positions him at the intersection of theoretical immunology and practical vaccinology applications. Current research trends reveal strong emphasis on collaborative computational validation frameworks, as demonstrated by his 2025 PLOS Computational Biology publication involving 40+ international researchers. The work establishes standardized testing protocols for immune modeling, signaling growing interdisciplinary convergence in immunoinformatics. As a core member of the Skin Immunology Research Center, he contributes to investigations of cutaneous immune mechanisms, though specific lab structures or team compositions remain undocumented in available sources.
Frank Kjeldsen is a Professor and group leader in the Protein Research group at the Department of Biochemistry and Molecular Biology , University of Southern Denmark . His research focuses on proteomics, mass spectrometry, and the biological effects of nanoparticles, with a strong emphasis on method development in negative ion mode and ultrafast proteomic platforms. His research interests span: Proteomics and systems biology Nanoparticle-biological system interactions Development of novel mass spectrometry and chemical biology methods Fundamental gas-phase peptide chemistry Metabolomics and multi-omics integration Recent publications (2023–2025) highlight trends in ultrafast proteomics , multi-omics for environmental and biomedical applications, nanoplastic toxicity , and neuroprotection . His work frequently involves advanced LC-MS/MS techniques, ion mobility, and software development for data analysis. Scientific recognition includes: 2 prizes (as noted in his CV profile) He actively supervises research and collaborates on multiple interdisciplinary projects. His lab, the Frank Kjeldsen Lab , is part of the Biomedical Mass Spectrometry research section. He has contributed to numerous grants and collaborative research efforts in toxicology, cancer, and environmental science.
Birgitte H. Kallipolitis is a Professor in Molecular Microbiology at the Department of Biochemistry and Molecular Biology, University of Southern Denmark. She has held academic positions at the institution since 2001, progressing from Assistant Professor to full Professor in 2017. Her research is centered on gene regulatory mechanisms in Gram-positive pathogens, particularly Listeria monocytogenes and Staphylococcus aureus . Ph.D. : Molecular Biology, University of Southern Denmark, 1997 Postdoctoral Fellow : University of Copenhagen Visiting Scientist : University College Cork, Ireland Her research interests lie at the intersection of molecular microbiology and gene regulation. She investigates how small regulatory RNAs (sRNAs), two-component systems, and environmental signals such as fatty acids control bacterial virulence, stress responses, and antibiotic resistance. Her work provides critical insights into the molecular mechanisms that enable pathogens to survive in hostile environments and cause disease. Using advanced molecular and biochemical techniques, her group studies RNA-protein and RNA-RNA interactions, transcriptional regulation, and post-transcriptional control in bacterial systems. The publication trends over the last five years reflect a strong focus on Listeria monocytogenes virulence regulation by fatty acids and sRNAs, stress response systems like LisRK, and the role of surface proteins in Staphylococcus aureus biofilms. Her recent work also includes methodological contributions in RNA analysis and genomic epidemiology of resistant pathogens. The keywords across her articles highlight consistent themes in RNA biology , gene regulation , infection mechanisms , and antimicrobial strategies . Scientific Awards: Prize (1 mentioned in profile) Professor Kallipolitis has supervised several Ph.D. and Master’s students, including E. M. S. Lillebæk, P. T. Dos Santos, and M. Thorsing, and has been involved in numerous research projects funded by national and international grants. Her work has significant implications for understanding bacterial pathogenesis and developing novel anti-infective strategies. She leads the Molecular Microbiology research section and manages a biosafety level 2 laboratory equipped for infection studies using C. elegans and cultured mammalian cells. Research Group: The Kallipolitis Lab, also known as the Molecular Microbiology group, focuses on RNA and protein-based regulatory systems in Gram-positive bacteria. The lab maintains facilities for molecular cloning, gene expression analysis, protein purification, and infection assays, contributing to a comprehensive understanding of bacterial gene regulation and host-pathogen interactions.
